(ShareCast News) - Global investor Advent International has entered into exclusive negotiations with French pharmaceutical group Sanofi about the acquisition of its European generics business, Zentiva, for €1.9bn. Advent's offer is firm, binding …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
In keeping with the commitment to dynamically provide members with timely information WallStEquities.com has issued …
Shares of Sanofi SA (SNYNF,SNY) were losing around 2 percent in the morning trading in Paris after the French drug giant reported Thursday a decline in third quarter profit, while net sales were slightly higher amid negative currency …
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing …
After declining in 2016, share price of French pharma giant Sanofi SNY has picked up in 2017. This Zacks Rank #2 (Buy) stock has risen 21.1% this year so far, outperforming the return of the Zacks classified Large-Cap Pharma industry of …